Suven Pharmaceuticals Performance

Day Range

Low 602
High 641

₹ 617

52 Week Range

Low 469
High 768

₹ 617

Open Price610
Previous Close632
Volume903867

Suven Pharmaceuticals Share Price

Over 1 Month -5.16%
Over 3 Month -3.94%
Over 6 Month -5.81%
Over 1 Year +29.47%

Suven Pharmaceuticals Key Statistics

P/E Ratio	52.3
PEG Ratio	-1.9
Market Cap Cr	15,714
Price to Book Ratio	7.7
EPS	16.6
Dividend	0
Relative Strength Index	39.15
Money Flow Index	27.32
MACD Signal	-3.42
Average True Range	20.3

Suven Pharmaceuticals Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios

Indicator	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Oper Rev Qtr Cr	244	213	225	344	364
Operating Expenses Qtr Cr	171	145	127	174	190
Operating Profit Qtr Cr	72	68	97	170	175
Depreciation Qtr Cr	16	11	10	11	11
Interest Qtr Cr	2	1	1	1	2
Tax Qtr Cr	18	17	26	43	42
Net Profit Qtr Cr	53	52	75	124	130

Indicator	Mar 2024	Mar 2023
Total Revenue Annual Cr	1,080	1,375
Operating Expenses Annual Cr	615	747
Operating Profit Annual in Cr	410	583
Depreciation Cr	49	43
Interest Annual Cr	7	5
Tax Annual Cr	104	147
Net Profit Annual Cr	305	433

Indicator	Mar 2024	Mar 2023
Cash from Operating Activity Annual Cr		484
Cash from Investing Activity Annual Cr		-236
Cash from Financing Annual Activity Cr		-236
Net Cash Flow Annual Cr		13

Indicator	Mar 2024	Mar 2023
Total ShareHolders Funds Annual Cr	2,056	1,749
Fixed Assets Annual Cr	703	677
Total Non Current Assets Annual Cr	1,031	1,003
Total Current Assets Annual Cr	1,210	955
Total Assets Annual Cr	2,241	1,958

Indicator	Mar 2024	Mar 2023
Book Value Per Share Annual Rs	81	69
ROE Annual %	15	25
ROCE Annual %	19	32
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	45	47

Indicator	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Oper Rev Qtr Cr	253	220	231	348	369
Operating Expenses Qtr Cr	180	155	133	181	200
Operating Profit Qtr Cr	73	65	98	167	169
Depreciation Qtr Cr	17	13	12	13	12
Interest Qtr Cr	2	1	1	1	2
Tax Qtr Cr	17	19	26	43	42
Net Profit Qtr Cr	53	47	80	121	124

Indicator	Mar 2024	Mar 2023
Total Revenue Annual Cr	1,113	1,387
Operating Expenses Annual Cr	646	774
Operating Profit Annual in Cr	406	567
Depreciation Cr	55	48
Interest Annual Cr	7	5
Tax Annual Cr	105	148
Net Profit Annual Cr	300	411

Indicator	Mar 2024	Mar 2023
Cash from Operating Activity Annual Cr		451
Cash from Investing Activity Annual Cr		-195
Cash from Financing Annual Activity Cr		-236
Net Cash Flow Annual Cr		20

Indicator	Mar 2024	Mar 2023
Total ShareHolders Funds Annual Cr	2,051	1,735
Fixed Assets Annual Cr	849	828
Total Non Current Assets Annual Cr	991	955
Total Current Assets Annual Cr	1,263	1,011
Total Assets Annual Cr	2,254	1,966

Indicator	Mar 2024	Mar 2023
Book Value Per Share Annual Rs	81	68
ROE Annual %	15	24
ROCE Annual %	19	31
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	44	46

Invest in Suven Pharmaceuticals

Suven Pharmaceuticals Technicals

EMA & SMA

Current Price

₹617.3

-14.75 (-2.33%)

Bullish Moving Average
___
0

Bearish Moving Average
___
16

EMA SMA

20 Day
₹639.98

50 Day
₹645.68

100 Day
₹644.10

200 Day
₹619.29

20 Day
₹643.75

50 Day
₹643.82

100 Day
₹657.75

200 Day
₹623.46

Suven Pharmaceuticals Resistance and Support

PIVOT

₹619.99

Resistance
First Resistance	637.97
Second Resistance	658.63
Third Resistance	676.62

RSI	39.15
MFI	27.32
MACD Single Line	-3.42
MACD	-5.16

Support
First Support	599.32
Second Support	581.33
Third Supoort	560.67

Suven Pharmaceuticals Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	925,378	53,440,580	57.75
Week	259,820	14,885,099	57.29
1 Month	148,001	9,190,848	62.1
6 Month	379,864	21,542,065	56.71

Suven Pharmaceuticals Result Highlights

Suven Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Suven Pharmaceutical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1330.08 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2023. Suven Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24299TG2018PLC128171 and registration number is 128171.

Market Cap	15,629
Sales	1,025
Shares in Float	12.73
No of funds	167
Yield	0.18

Book Value	8.93
U/D Vol ratio	1
LTDebt / Equity	2
Alpha	0.07
Beta	0.58

Suven Pharmaceuticals Shareholding Pattern

Owner Name	Mar-24	Dec-23	Sep-23	Jun-23
Promoters	50.1%	60%	60%	60%
Mutual Funds	15.26%	13.4%	12.15%	9.12%
Insurance Companies	1.57%	1.89%	1.38%	0.11%
Foreign Portfolio Investors	9.54%	10.14%	10.01%	9.5%
Financial Institutions/ Banks
Individual Investors	10.51%	10.87%	11.76%	12.8%
Others	13.02%	3.7%	4.7%	8.47%

Suven Pharmaceuticals Management

Name	Designation
Mr. Annaswamy Vaidheesh	Executive Chairman
Mr. V Prasada Raju	Managing Director
Mr. Pankaj Patwari	Non Exe.Non Ind.Director
Ms. Shweta Jalan	Non Exe.Non Ind.Director
Ms. Matangi Gowrishankar	Independent Director
Mr. Vinod Rao	Independent Director
Mr. K G Ananthakrishnan	Independent Director
Mr. Pravin Rao Udhyavara Bhadya#	Independent Director

Suven Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)

1,758(-3.5%)

1,590(-12.7%)

Other Analyst Rating

Date	Purpose	Remarks
2024-05-30	Audited Results	(Revised) per share(100%)Interim Dividend
2024-02-05	Quarterly Results
2023-11-09	Quarterly Results
2023-08-08	Quarterly Results
2023-05-25	Audited Results

Date	Purpose	Remarks
2022-09-12	INTERIM	Rs.1.00 per share(100%)Interim Dividend
2022-09-12	SPECIAL	Rs.5.00 per share(500%)Special Dividend
2022-05-17	INTERIM	Re.1.00 per shaer (100%) Second Interim Dividend
2022-05-17	SPECIAL	Rs.1.00 per share(100%)Special Dividend
2022-02-16	INTERIM	Rs.1.00 per share(100%)Interim Dividend

Suven Pharmaceuticals MF Shareholding

Name	Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth	24,295
Axis Small Cap Fund Regular Growth	20,137
DSP ELSS Tax Saver Fund Regular Plan Growth	14,860
HSBC Small Cap Fund Fund Regular Growth	14,619
DSP Equity Opportunities Fund Growth	11,631

Suven Pharmaceuticals FAQs

What is Share Price of Suven Pharmaceuticals ?

Suven Pharmaceuticals share price is ₹617 As on 31 May, 2024 | 20:14

What is the Market Cap of Suven Pharmaceuticals ?

The Market Cap of Suven Pharmaceuticals is ₹15714.3 Cr As on 31 May, 2024 | 20:14

What is the P/E ratio of Suven Pharmaceuticals ?

The P/E ratio of Suven Pharmaceuticals is 52.3 As on 31 May, 2024 | 20:14

What is the PB ratio of Suven Pharmaceuticals ?

The PB ratio of Suven Pharmaceuticals is 7.7 As on 31 May, 2024 | 20:14

Suven Pharmaceuticals Key Statistics

P/E Ratio	52.3
PEG Ratio	-1.9
Market Cap Cr	15,714
Price to Book Ratio	7.7
EPS	16.6
Dividend	0
Relative Strength Index	39.15
Money Flow Index	27.32
MACD Signal	-3.42
Average True Range	20.3

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91